Chinese medicinal herbs for reducing endocrine therapy-induced side effects in patients with hormone receptor‐positive breast cancer: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Chinese medicinal herbs for reducing endocrine therapy-induced side effects in patients with hormone receptor‐positive breast cancer: a systematic review and meta-analysis

Published:2023-04-25 Issue:1 Volume:61 Page:722-736
ISSN:1388-0209
Container-title:Pharmaceutical Biology
language:en
Short-container-title:Pharmaceutical Biology

Author:

Chen Shaoqing¹,Gao Yifang²,Liu Haichao¹,Jing Jin¹,Yang Zhengyu¹,Zhu Haoming¹,Chen Bairui¹,Wang Yu¹,Zhang Ting²,Wang Shizhong²³,Lin Jianping²³

Affiliation:

1. College of Rehabilitation Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, China

2. School of Health, Fujian Medical University, Fuzhou, China

3. Fujian Provincial Collaborative Innovation Center of Geriatric Rehabilitation and Industry Promotion, Fuzhou, China

Funder

National Natural Science Foundation of China

Publisher

Informa UK Limited

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13880209.2023.2203193

Reference60 articles.

1. Advances in Endocrine-Based Therapies for Estrogen Receptor-Positive Metastatic Breast Cancer

2. Shugan Tiaoyinyang Fang in ameliorating symptoms caused by tamoxifen after breast cancer surgery and improving the quality of life：aRCT;Bian WH;J Nanjing Univ Trad Chin Med,2013

3. Trends in complementary/alternative medicine use by breast cancer survivors: Comparing survey data from 1998 and 2005

4. Effect of Fuzheng Xiaoliu decoction on quality of life, inflammatory factors and sex hormones in postmenopausal breast cancer endocrine therapy patients;Cai JY;Shenzhen J Integr Tradit Chin West Med,2021

5. Effect of Chaiguilongmu decoction in improving adverse reactions of endocrine therapy for breast cancer: a randomized double-blind controlled study;Cai LL;China Pharm,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticancer effects of Erzhimaoling decoction in high-grade serous ovarian cancer in vitro and in vivo;European Journal of Medical Research;2024-08-05

2. Ginsenoside Rh4 Facilitates the Sensitivity of Renal Cell Carcinoma to Ferroptosis via the NRF2 Pathway;Archivos Españoles de Urología;2024